Crafting the Molecular Keyring: Library Construction for Targeted Aptamer Discovery
Aptamers are single-stranded DNA or RNA molecules obtained through in vitro selection techniques (SELEX) from random oligonucleotide libraries, capable of binding to target molecules with High Affinity and Specificity. The success of aptamer screening highly depends on the quality and diversity of the initial aptamer library.
The core of library construction lies in designing a large-capacity oligonucleotide library with rich sequence space. Its basic structure generally consists of fixed primer-binding regions at both ends for PCR amplification, and a central random sequence region of 20–50 nucleotides in length, which determines the theoretical capacity of the library. Library design often varies depending on the target.
Library Design Strategies for Small Molecule Targets
Small molecule targets (such as antibiotics, toxins, or hormones) have low molecular weights and limited epitopes. Their binding typically occurs in a shallow groove or crevice, so excessively long random sequences are unnecessary. Overly long random regions may even promote non-specific folding and reduce the abundance of effective binding sequences. The key to designing a small molecule-targeted library lies in ensuring diversity within the limited sequence space.
To achieve this, researchers commonly adopt two strategies:
(i) Introducing functional groups or structural units into the library to pre-endow it with the potential for interaction with small molecules.
(ii) Employing a truncation or sub-library strategy—using a large primary library for initial screening, then constructing a secondary library with a shorter and more focused random region based on the positive sequences obtained as a backbone.
This allows for more refined screening and improves the efficiency of selection. This refined approach to small molecule aptamer library construction, combined with efficient SELEX screening technology, significantly enhances the success rate of obtaining high-affinity aptamers.
Fig 1 RNA Capture–SELEX
Library Construction and Optimization for Protein Targets
Compared to small molecule aptamer library construction, protein targets have larger and more complex binding epitopes on their surfaces. Therefore, protein aptamer library construction generally require longer random regions and larger capacities. Protein epitopes can be either conformational or linear, necessitating that the random sequences in the library be able to fold into various complex three-dimensional structures—such as G-quadruplexes, hairpins, and bulges—to achieve precise recognition.
In addition to sequence length and capacity, the stability and functionality of the library are also crucial, especially for RNA libraries. Ribonucleotides are susceptible to degradation by nucleases in serum, which can severely impact subsequent production and application. Therefore, during protein aptamer library construction, chemically modified nucleotides are typically incorporated into the transcription process. This approach creates an initial library with high nuclease resistance at the source. This optimized protein aptamer library construction strategy provides a foundation for subsequent multiple rounds of screening, ensuring the identification of aptamers that possess both high affinity and stable existence.
Complex Library Strategies for Cell-Level Screening
Cell-SELEX library construction is one of the most advanced and complex areas in aptamer technology. The targets are no longer purified single molecules, but rather complex membrane proteomes or other surface molecules on living cells. This “cell-as-target” strategy enables direct screening of aptamers for disease cell recognition or targeted therapy without prior knowledge of specific membrane protein information. Therefore, cell ligand libraries used for such screening must possess extremely high diversity and large capacity to cover all possible binding scenarios.
The challenge of this strategy lies in enriching sequences that truly bind to specific disease cell surface markers from a vast pool, while also minimizing interference from sequences that bind to normal cells or common cell surface components. To address this, sophisticated counter-selection steps are often introduced: before or after each positive selection round, the library is incubated with control cells, and unbound sequences are collected to deplete those binding to non-specific targets. In this way, the effectiveness of cell ligand library construction is greatly enhanced. Combined with SELEX screening technology, highly specific aptamers can be successfully obtained.
Fig 2 The technical process of constructing, expressing and functionally screening a protein adapter library mediated by mammalian cells
From the precise design of small molecule aptamer library construction, to the stability modifications of protein aptamer library construction, and further to the complex counter-selection strategies in cell-SELEX library construction, Alpha Lifetech is committed to providing customized screening services for every client.
Reference
[1] Ellington AD, Szostak JW. In vitro selection of RNA molecules that bind specific ligands. Nature. 1990 Aug 30;346(6287):818-22.
[2] Hermann T, Patel DJ. Adaptive recognition by nucleic acid aptamers. Science. 2000 Feb 4;287(5454):820-5.
[3] Brown A, Brill J, Amini R, Nurmi C, Li Y. Development of Better Aptamers: Structured Library Approaches, Selection Methods, and Chemical Modifications. Angew Chem Int Ed Engl. 2024 Apr 15;63(16):e202318665.
[4] Legen T, Mayer G. Robotic-Assisted Capture-Systematic Evolution of Ligands by Exponential Enrichment of RNA Aptamers Binding to Small Molecules. Chembiochem. 2025 Aug 22;26(15):e202500264.
[5] Wang Y, Zhang K, Zhao Y, Li Y, Su W, Li S. Construction and Applications of Mammalian Cell-Based DNA-Encoded Peptide/Protein Libraries. ACS Synth Biol. 2023 Jul 21;12(7):1874-1888.
FAQs
Q1: After the construction of a secondary library for small molecule aptamers, how is its binding performance verified to be superior to the primary library?
A1: Verification must address both affinity and specificity. Firstly, fluorescence polarization or surface plasmon resonance (SPR) technology can be used to detect the dissociation constant (Kd) of aptamers from the secondary library binding to the target small molecule. If the Kd value decreases by 1-2 orders of magnitude compared to the primary library, it indicates improved affinity. Secondly, specificity testing is necessary; incubate the aptamers with structurally similar small molecules. If binding occurs only with the target small molecule, it proves enhanced specificity. Additionally, observe the aptamer-target complex bands via gel shift assay; sharper bands with fewer non-specific bands indicate higher abundance of effective binding sequences and overall performance superior to the primary library.
Q2: If the target molecule is a conjugate of a small molecule and a protein (e.g., a drug-protein complex), how should the aptamer library be designed?
A2: A “comprehensive” design strategy is required. First, determine the length of the library’s random region, selecting 30-40 nucleotides considering the characteristics of both entities. This length accommodates the complex folded structures needed for protein epitopes while avoiding redundancy in the small molecule binding region sequence. Secondly, incorporate targeted designs within the random region: for the protein part, retain sequence backbones capable of forming G-quadruplexes and hairpin structures; for the small molecule part, include functional groups containing hydroxyl or amino groups to enhance hydrogen bonding interactions with the small molecule. Screening can be conducted in stages: first, perform initial screening using the protein as the target to enrich sequences binding to the protein; then add the small molecule to form the conjugate for secondary screening, selecting aptamers that recognize both, thereby enhancing library targeting.
Q3: When customizing an aptamer library, what key information should the client provide to the service provider to ensure customization effectiveness?
A3:(i) Target details, including target type, molecular weight and structure of small molecules, protein purity and source, cell line name and culture conditions.
(ii) Intended application scenario, such as for in vitro detection, in vivo targeting, or cell sorting.
(iii) Library parameter preferences, such as random region length, whether chemical modification is required.
(iv) Screening objectives, such as the desired dissociation constant (Kd) range, whether specific cross-reactivities need to be excluded.
Q4: What are the main advantages and disadvantages of aptamers compared to monoclonal antibodies in applications?
A4:Advantages: Aptamers exhibit high batch-to-batch consistency due to their precise and controllable chemical synthesis process, avoiding the inter-batch variability seen in antibodies caused by individual animal differences or cell culture variations. They are easily modified and labeled; reporter molecules such as fluorophores or biotin can be precisely incorporated onto specific nucleotides during synthesis without affecting activity. They offer a broader target range, enabling selection against targets with weak immunogenicity or high toxicity. They possess better stability; DNA aptamers can be transported and stored long-term at room temperature without denaturation easily.
Disadvantages: Aptamers have a small molecular weight, leading to rapid clearance via the kidneys and a short in vivo half-life, often requiring conjugation to polymers like PEG to extend circulation time. They lack effector functions like the Fc region of antibodies, unable to directly mediate ADCC or CDC effects. As a relatively new technology, their clinical translation and regulatory approval pathway have less accumulated experience compared to well-established antibody drugs.